Innovative treatments for irritable bowel syndrome featured in new continuing ed program.
D002243:Carbolines / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003109:Colonic Diseases, Functional / Q000175:diagnosis / Q000188:drug therapy*; D003248:Constipation; D003967:Diarrhea; D004502:Education, Medical, Continuing; D005260:Female; D006801:Humans; D016896:Treatment Outcome; D014481:United States
D002243:Carbolines